Risk of fatal adverse events after H1N1 influenza vaccine: limitations of passive surveillance data

Clin Infect Dis. 2010 Oct 1;51(7):871-2; author reply 872-3. doi: 10.1086/656295.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Aged
  • Aged, 80 and over
  • Drug-Related Side Effects and Adverse Reactions / mortality*
  • Humans
  • Influenza A Virus, H1N1 Subtype / immunology
  • Influenza Vaccines / adverse effects*
  • Japan
  • Middle Aged
  • Risk Assessment*
  • Vaccines, Inactivated / adverse effects

Substances

  • Influenza Vaccines
  • Vaccines, Inactivated